Twist Bioscience to Present at Upcoming Virtual Investor Conferences

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences:

Metadata

Provider:

Business Wire, Inc.

Retrieved on:

Tuesday, November 24, 2020

Information

Tags:

Technology, Research, Genetics, Nanotechnology, Biotechnology, Health, Pharmaceutical, Other Science, Science, Articles, Twist Bioscience, Branches of biology, Life sciences, Synthetic biology, Evercore, Genomics

Geotags:

United States, California

⚠ generated by AI ↴

Organisation:

TWIST BIOSCIENCE CORPORATION

Summary

Key Points:

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences:
Piper Sandler 32nd Annual Virtual Healthcare Conference, recorded fireside chat available at 8:00 a.m.
ET on Monday, November 30
2020 Evercore ISI HealthCONx Conference on Tuesday, December 1 at 1:50 p.m.
ET
Both presentations can be accessed by visiting the Investor Calendar page of the investor relations section of the companys website here .
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences:

Piper Sandler 32nd Annual Virtual Healthcare Conference, recorded fireside chat available at 8:00 a.m. ET on Monday, November 30
2020 Evercore ISI HealthCONx Conference on Tuesday, December 1 at 1:50 p.m. ET

Both presentations can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company’s website here. A replay of the presentations will be archived for a period of 90 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201124005405/en/